The pharmacogenomics (PGx) field, which studies how an individual’s genetic makeup influences their response to medications, enables personalized treatment plans that enhance efficacy while minimizing adverse effects.
BITSCOPIC sought to illustrate the synergies between PGx and its clinical report-generating system, PraediGene, which enhances the U.S. Department of Veterans Affairs’ (VA’s) capabilities in precision medicine.
Clarity Quest wrote and designed an eight-page executive brief, Advancing Pharmacogenomics with Real-World VA Patient Data. It highlights recent VA PGx initiatives and how PraediGene can automate the integration of genetic screening results into veterans’ health records for maximum benefit.
The executive brief incorporates various studies related to adverse drug reactions, polypharmacy, and medical cost savings to make a strong case for PraediGene support. The piece also looks ahead to potential future applications, such as the integration of multi-omics analysis.
